Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization

Annals of Surgical Oncology

Volumn 17, Issue 8, 2010, Pages 2081-2089

  De Baere, Thierry ^a   Teriitehau, Christophe ^a   Deschamps, Frederic ^a   Catherine, Laurence ^a   Rao, Pramod ^a   Hakime, Antoine ^a   Auperin, Anne ^a   Goere, Diane ^a   Elias, Dominique ^a   Hechelhammer, Lukas ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; FEMALE; HUMAN; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE TREATMENT; RADIOFREQUENCY ABLATION; THROMBOCYTE COUNT; HYPERTROPHY; LIVER; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SURGERY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; HYPERTROPHY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954917935     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0979-2     Document Type: Article

References (40)

1. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304-9.
2. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002;137:675-80; discussion 680-1.
3. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al. Volumetric analysis predicts hepatic dys-function in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325-30.
4. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-57; discussion 657-8.
5. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480-6.
6. Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK, Belghiti J. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl. 2003;9: S18-25.
7. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803-8.
8. de Baere T, Roche A, Vavasseur D, Therasse E. Portal vein embolisation: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology. 1993;188:73-7.
9. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-72.
10. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol. 2005;16:779-90.
11. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology. 1993;18:79-85.
12. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003;237:686-91; discussion 691-3.
13. de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;24:1386-91.
14. Elias D, Santoro R, Ouellet JF, Osmak L, de Baere T, Roche A. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology. 2004;51:1788-91.
15. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099-105.
16. Kaido T, Arii S, Shimada Y, Mori A, Imamura M. Portal embolization in various types of liver: novel variables to predict hypertrophy. Hepatogastroenterology. 2003;50:140-5.
17. Fujii Y, Shimada H, Endo I, Morioka D, Nagano Y, Miura Y, et al. Risk factors of posthepatectomy liver failure after portal vein embolization. J Hepatobiliary Pancreat Surg. 2003;10:226-32.
18. Goere D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10:365-70.
19. Kobayashi S, Nagino M, Yokoyama Y, Nimura Y, Sokabe M. Evaluation of hepatic interleukin-6 secretion following portal vein ligation using a minimal surgical stress model. J Surg Res. 2006;135:27-33.
20. Nanashima A, Sumida Y, Shibasaki S, Takeshita H, Hidaka S, Sawai T, et al. Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res. 2006;133:95-101.
21. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091-8.
22. Denys A, Lacombe C, Schneider F, Madoff DC, Doenz F, Qanadli SD, et al. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol. 2005;16:1667-74.
23. Covey AM, Tuorto S, Brody LA, Sofocleous CT, Schubert J, von Tengg-Kobligk H, et al. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol. 2005;185:1620-6.
24. Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y. Liver regeneration after major hepatectomy for biliary cancer. Br J Surg. 2001;88:1084-91.
25. Tani M, Tomiya T, Yamada S, Hayashi S, Yahata K, Tamura Y. Regulating factors of liver regeneration after hepatectomy. Cancer Chemother Pharmacol. 1994;33: S29-S32.
26. Bucher NL, Swaffield MN. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res. 1964;24:1611-25.
27. Yuceturk H, Yagmurdur MC, Gur G, Demirbilek M, Bilezikci B, Turan M, et al. Role of heparin on TNF-alpha and IL-6 levels in liver regeneration after partial hepatic resection. Eur Surg Res. 2007;39:216-21.
28. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1-7. (Pubitemid 43054046)
29. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-72.
30. Beal IK, Anthony S, Papadopoulou A, Hutchins R, Fusai G, Begent R, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol. 2006;79:473-8.
31. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451-5.
32. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460-6.
33. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008;15:2765-72.
34. Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000;127:155-60.
35. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery. 2008;144:74451.
36. de Baere T, Denys A, Paradis V. Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol. 2009;19:1435-41.
37. Breen DJ, Rutherford EE, Stedman B, Lee-Elliott C, Hacking CN. Intrahepatic arterioportal shunting and anomalous venous drainage: understanding the CT features in the liver. Eur Radiol. 2004;14:2249-60.
38. Arai K, Matsui O, Takashima T, Ida M, Nishida Y. Focal spared areas in fatty liver caused by regional decreased portal flow. AJR Am J Roentgenol. 1988;151:300-2.
39. Takayasu K, Aoki K, Ichikawa T, Ohmura T, Sekiguchi R, Terauchi T, et al. Aberrant right gastric vein directly communicating with left portal vein system. Incidence and implications. Acta Radiol. 1990;31:575-7.
40. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104-7.